EUVIMEDEUVIMED entdecken
Open Access

Association of Indication for Hospitalization With Subsequent Amyloid Positron Emission Tomography and Magnetic Resonance Imaging Biomarkers

Juraj Sprung iD, Mariana L Laporta, David S Knopman, Ronald C Petersen, Michelle M Mielke iD, Clifford R Jack, David P Martin, Andrew C Hanson, Darrell R Schroeder, Phillip J Schulte, Scott A Przybelski, Diana J Valencia Morales iD und 3 weitere

The Journals of Gerontology: Series A · 2023

DOI: 10.1093/gerona/glac064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, 2023. Verfasst von Juraj Sprung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, White Matter. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hospitalization in older age is associated with accelerated cognitive decline, typically preceded by neuropathologic changes. We assess the association between indication for hospitalization and brain neurodegeneration.

Methods

Included were participants from the Mayo Clinic Study of Aging, a population-based longitudinal study, with ≥1 brain imaging available in those older than 60 years of age between 2004 and 2017. Primary analyses used linear mixed-effects models to assess association of hospitalization with changes in longitudinal trajectory of cortical thinning, amyloid accumulation, and white matter hyperintensities (WMH). Additional analyses were performed with imaging outcomes dichotomized (normal vs abnormal) using Cox proportional hazards regression.

Results

Of 2 480 participants, 1 966 had no hospitalization and 514 had ≥1 admission. Hospitalization was associated with accelerated cortical thinning (annual slope change −0.003 mm [95% confidence interval (CI) −0.005 to −0.001], p = .002), but not amyloid accumulation (0.003 [95% CI −0.001 to 0.006], p = .107), or WMH increase (0.011 cm3 [95% CI −0.001 to 0.023], p = .062). Interaction analyses assessing whether trajectory changes are dependent on admission type (medical vs surgical) found interactions for all outcomes. While surgical hospitalizations were not, medical hospitalizations were associated with accelerated cortical thinning (−0.004 mm [95% CI −0.008 to −0.001, p = .014); amyloid accumulation (0.010, [95% CI 0.002 to 0.017, p = .011), and WMH increase (0.035 cm3 [95% CI 0.012 to 0.058, p = .006). Hospitalization was not associated with developing abnormal cortical thinning (p = .407), amyloid accumulation (p = .596), or WMH/infarctions score (p = .565).

Conclusions

Medical hospitalizations were associated with accelerated cortical thinning, amyloid accumulation, and WMH increases. These changes were modest and did not translate to increased risk for crossing the abnormality threshold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionWhite MatterHumansLongitudinal StudiesCerebral Cortical ThinningMagnetic Resonance ImagingPositron-Emission TomographyAmyloidAmyloidogenic ProteinsBiomarkersAmyloid beta-Peptides

Stichwörter der Autor:innen

AmyloidCortical thicknessHospitalizationMedicalSurgicalWhite matter hyperintensities

Substanzen

AmyloidAmyloidogenic ProteinsBiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Juraj Sprung, Michelle M Mielke, Diana J Valencia Morales, Toby N Weingarten, Prashanthi Vemuri, David O Warner

Förderung

  • NIA NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • Mayo Clinic Center for Clinical and Translational Science
  • National Center for Advancing Translational Sciences

Zitieren

APA

Sprung, J., Laporta, M. L., Knopman, D. S., Petersen, R. C., Mielke, M. M., Jack, C. R., Martin, D. P., Hanson, A. C., Schroeder, D. R., Schulte, P. J., Przybelski, S. A., Valencia Morales, D. J., Weingarten, T. N., Vemuri, P., & Warner, D. O. (2023). Association of Indication for Hospitalization With Subsequent Amyloid Positron Emission Tomography and Magnetic Resonance Imaging Biomarkers. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glac064

Vancouver

Sprung J, Laporta ML, Knopman DS, Petersen RC, Mielke MM, Jack CR, et al. Association of Indication for Hospitalization With Subsequent Amyloid Positron Emission Tomography and Magnetic Resonance Imaging Biomarkers. The Journals of Gerontology: Series A. 2023. doi:10.1093/gerona/glac064

BibTeX
@article{Sprung2023,
  author = {Sprung, Juraj and Laporta, Mariana L and Knopman, David S and Petersen, Ronald C and Mielke, Michelle M and Jack, Clifford R and Martin, David P and Hanson, Andrew C and Schroeder, Darrell R and Schulte, Phillip J and Przybelski, Scott A and Valencia Morales, Diana J and Weingarten, Toby N and Vemuri, Prashanthi and Warner, David O},
  title = {Association of Indication for Hospitalization With Subsequent Amyloid Positron Emission Tomography and Magnetic Resonance Imaging Biomarkers},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  doi = {10.1093/gerona/glac064}
}
Kostenlos starten →